Mesenchymal Cell News Volume 6.29 | Aug 5 2014

Equine Mesenchymal Stromal Cells and Embryo-Derived Stem Cells Are Immune Privileged In Vitro
No immune response is reported following in vivo injection of allogeneic equine mesenchymal stem cells or embryo-derived stem cells into the equine tendon, which may be due to the cells’ immune privileged properties. Researchers investigated these properties to determine their potential for clinical application in other tissues. [Stem Cell Res Ther] Abstract | Full Article

Non-Pulsed Sinusoidal Electromagnetic Fields as a Noninvasive Strategy in Bone Repair: The Effect on Human Mesenchymal Stem Cell Osteogenic Differentiation
Scientists studied the effect of non-pulsed sinusoidal electromagnetic field radiation tuned at calcium-ion cyclotron frequency of 50 Hz exposure treatment for bone differentiation of human mesenchymal stem cells alone or in synergy with dexamethasone, their canonical chemical differentiation agent. [Tissue Eng Part C Methods] Abstract

Discovery and Characterization of miRNA during Cellular Senescence in Bone Marrow-Derived Human Mesenchymal Stem Cells
Investigators identified and characterized miRNAs during cellular senescence in mesenchymal stem cells (MSCs). 19 miRNAs showed upregulated expression patterns in senescent MSCs compared with young MSCs, and five miRNAs were downregulated. [Exp Gerontol] Abstract

A p38 MAPK-Mediated Alteration of COX-2/PGE2 Regulates Immunomodulatory Properties in Human Mesenchymal Stem Cell Aging
Scientists evaluated the effect of replicative senescence on the immunomodulatory ability of human mesenchymal stem cells (hMSCs) in vitro and in vivo. Late-passage hMSCs showed impaired suppressive effect on mitogen-induced mononuclear cell proliferation. [PLoS One] Full Article

Enhanced Healing of Rat Calvarial Defects with MSCs Loaded on BMP-2 Releasing Chitosan/Alginate/Hydroxyapatite Scaffolds
Investigators evaluated the effect of the chitosan/alginate/hydroxyapatite scaffold as a carrier for recombinant BMP-2 scaffold on the viability and differentiation of bone marrow mesenchymal stem cells (MSCs) by scanning electron microscopy, MTS, ALP assay, alizarin-red staining and qRT-PCR. [PLoS One] Full Article

Therapeutic Effects of Mesenchymal Stem Cell-Derived Microvesicles on Pulmonary Arterial Hypertension in Rats
Scientists investigated the therapeutic effects of mesenchymal stem cell derived microvesicles on pulmonary artery hypertension in rats. [Acta Pharmacol Sin] Abstract

Evaluation of New Bone Formation in Irradiated Areas Using Association of Mesenchymal Stem Cells and Total Fresh Bone Marrow Mixed with Calcium Phosphate Scaffold
The authors previously demonstrated the efficacy of biphasic calcium phosphate (BCP) and total fresh bone marrow (TBM) in regenerating irradiated bone defect. They studied whether adding mesenchymal stem cells to BCP + TBM mixture could improve the bone formation in irradiated bone defects. [J Mater Sci Mater Med] Abstract

Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.

Israel’s Ministry of Health Approves Pluristem’s Commercial-Scale 3D Cell Manufacturing Process Used at Its New Haifa Facility
Pluristem Therapeutics Inc. announced that it has completed the approval process and received final clearance from a fifth regulatory agency for its 3D cell therapy manufacturing processes in use at its new facility in Haifa. [Pluristem Therapeutics Inc.] Press Release

From our sponsor: Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

Visit our events page to see a complete list of events in the mesenchymal cell community.

NEW Cell Biology Technician (University of Pittsburgh School of Medicine)

NEW Postdoctoral Fellowship – Developing Applications of Mesenchymal Stromal/Stem Cells in Hematopoietic Cell Transplantation (The Research Institute at Nationwide Children’s Hospital)

Postdoctoral Positions – Tissue Engineering and Regenerative Medicine (University of the Andes)

Technical Account Manager (GlobalStem)

Postdoctoral Fellow – Crosstalk and Interactions between Skeletal Cells and the Blood Vessels of Bone (KU Leuven)

PhD Position – Pericyte Function and Dysfunction in CNS Disease (Lund University)

Postdoctoral Position – Mesenchymal Stem Cells (University of Southern California)

Scientist – Mesenchymal Stem and Progenitor Cell Biology (STEMCELL Technologies Inc.)

Scientist – Myogenic Progenitor Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.